Deals of the day-Mergers and acquisitions

Summit Therapeutics

02/10/2026 11:39

Oct 2 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Friday:

**  Europe's largest gas distributor Italgas said it had agreed to acquire a 22.5% stake in Portuguese gas distribution company Floene from Japan's Marubeni 8002.T and Toho Gas 9533.T for around €120 million. 
 nL6N45M13C

** AstraZeneca AZN.L and Daiichi Sankyo 4568.T have entered into a clinical collaboration with Summit Therapeutics SMMT.O to test their cancer drug, Datroway, in combination with Summit's ivonescimab across multiple tumour types, including lung and breast cancers. 
 nL6N45O0C1

** Chinese biotech company Abogen said it signed a licensing and option agreement worth about $7.8 billion with Swiss drug maker Novartis NOVN.S to advance RNA-based therapy. nL6N45O0E0 

** SK Group Chairman Chey Tae-won will sell a 2.26% stake in SK Corp for about 944 billion won ($699.5 million) to fund a divorce settlement, though he will remain the top shareholder of the holding firm of the South Korean conglomerate, the company said on Friday. 
 nL1N45O06F

** BAE Systems BAES.L is among the potential bidders that are in the early stages of exploring an offer for Robin Radar Systems, three people familiar with the matter told Reuters, in what could be one of the biggest European defence industry deals since last year. 
 nL6N45O0CM

** Italy's top insurer Generali GASI.MI said it had agreed to buy a 9.9% stake in Spain's Banco de Crédito Cooperativo for a total consideration of €150 million.nL6N45O0HH

** India's Shyam Metalics and Energy SHYE.NS said it has signed a deal with the Maharashtra government to invest 500 billion rupees ($5.19 billion) to set up a steel plant in the western state. 
 nL4N45O0HM

 (Reporting by Tyakshi Singh in Bengaluru)
 ((Tyakshi.Singh@thomsonreuters.com;))